scholarly article | Q13442814 |
P356 | DOI | 10.1016/S2352-4642(18)30023-3 |
P698 | PubMed publication ID | 30169253 |
P50 | author | Joanne F Aitken | Q63682319 |
Danny R Youlden | Q64214396 | ||
Lindsay Frazier | Q87933837 | ||
Sumit Gupta | Q39063420 | ||
Peter D Baade | Q40027158 | ||
Andrew S Moore | Q55458621 | ||
Patricia C Valery | Q62933394 | ||
P2093 | author name string | Adèle C Green | |
Vicky J Thursfield | |||
Leisa J Ward | |||
P2860 | cites work | Diagnostic delay in pediatric solid tumors: a population based study on determinants and impact on outcomes | Q82341419 |
Biological background of pediatric medulloblastoma and ependymoma: a review from a translational research perspective | Q24658389 | ||
Advances in Wilms Tumor Treatment and Biology: Progress Through International Collaboration | Q28083988 | ||
International incidence of childhood cancer, 2001-10: a population-based registry study. | Q30061737 | ||
Trends in incidence of childhood cancer in Australia, 1983-2006. | Q33658579 | ||
Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data | Q33779753 | ||
Prognostic model for predicting overall survival in children and adolescents with rhabdomyosarcoma | Q34174451 | ||
Population-based survival estimates for childhood cancer in Australia during the period 1997–2006 | Q34363570 | ||
Health disparities are important determinants of outcome for children with solid tumor malignancies. | Q35535515 | ||
Paediatric cancer stage in population-based cancer registries: the Toronto consensus principles and guidelines. | Q36051934 | ||
The evolution of the population-based cancer registry | Q36544543 | ||
Pediatric hodgkin lymphoma: maximizing efficacy and minimizing toxicity | Q36859966 | ||
Neuroblastoma: Therapeutic strategies for a clinical enigma | Q37708680 | ||
Childhood Rhabdomyosarcoma: New Insight on Biology and Treatment | Q37785820 | ||
Surgery for metastatic disease | Q38105245 | ||
Childhood cancer survival in Europe 1999-2007: results of EUROCARE-5--a population-based study | Q38423271 | ||
Non-Hodgkin lymphoma in children: a 20-year population-based epidemiologic study in western Sweden | Q40817205 | ||
International Classification of Childhood Cancer, third edition | Q49046725 | ||
Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe | Q57566986 | ||
Incidence of childhood cancer in France: National Children Cancer Registries, 2000–2004 | Q58317424 | ||
P433 | issue | 3 | |
P921 | main subject | childhood cancer | Q5097977 |
P304 | page(s) | 173-179 | |
P577 | publication date | 2018-02-01 | |
P1433 | published in | The Lancet Child & Adolescent Health | Q63883066 |
P1476 | title | Assessing the feasibility and validity of the Toronto Childhood Cancer Stage Guidelines: a population-based registry study | |
P478 | volume | 2 |
Q90168939 | A temperature-sensitive phase-change hydrogel of topotecan achieves a long-term sustained antitumor effect on retinoblastoma cells |
Q98953108 | Development of paediatric non-stage prognosticator guidelines for population-based cancer registries and updates to the 2014 Toronto Paediatric Cancer Stage Guidelines |
Q62487294 | Essential TNM: a registry tool to reduce gaps in cancer staging information |
Q92538521 | Let's Talk About BiTEs and Other Drugs in the Real-Life Setting for B-Cell Acute Lymphoblastic Leukemia |
Q91248914 | The Toronto Guidelines: a practical means for childhood cancer staging |
Search more.